Biggest News Aggregation in the World
๐Ÿ“ฐ Second Cohort News

Page 3 - Second Cohort News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Second Cohort. Real-time updates on events, politics, business and more.

PayNearby to start cross-border remittance services by Oct - Jammu Kashmir Latest News | Tourism

New Delhi, July 26: Fintech startup PayNearby will start a facility of inward cross-border remittance by October, allowing beneficiaries to withdraw the amount as per their requirement rather than taking the whole amount in one go. “The Reserve Bank has granted us the approval under the second cohort for cross-border remittance. India gets about USD 80 billion as remittance every year which either comes in cash or in bank account,” Anand Kumar Bajaj, Founder, MD & CEO, PayNearby ...
New Delhi Anand Kumar Bajaj Governance Infrastructure Ltd Gov Technologies Ltd Reserve Bank Kumar Bajaj

C3iHub, IIT Kanpur launches the second cohort of startups with the objective to foster the next generation of cybersecurity entrepreneurs

Kanpur : C3iHub, the Technology Innovation Hub on Cyber Security of Cyber Physical Systems Program on Innovation Ecosystem Building at IIT Kanpur, has launched the Second Cohort of 14 startups under the Startup Incubation Program at an event held on
Uttar Pradesh Tanima Hazra Sandeep Shukla Abhay Karandikar Ekta Kapoor Manindra Agrawal

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

FinancialNewsMedia.com: Increased Prevalence of Atopic Dermatitis Fueling Impressive Growth for Atopic Dermatitis Drugs

PALM BEACH, Fla., Nov. 30, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Atopic dermatitis is a chronic inflammatory skin condition characterized by red, itchy, swollen, and
United States Prnewswire Financialnewsmedia Kostenloser Wertpapierhandel Stefanie Johns Susanne Schaffert Georged Yancopoulos

Investegate |Ultimovacs ASA Announcements | Ultimovacs ASA: Ultimovacs Begins Dosing of Second Cohort in Phase I TENDU Study Investigating Prostate Cancer-Specific Therapeutic Vaccine

Investegate announcements from Ultimovacs ASA, Ultimovacs Begins Dosing of Second Cohort in Phase I TENDU Study Investigating Prostate Cancer-Specific Therapeutic Vaccine
Mary Ann Chang Hans Vassg Company Tetanus Oslo University Hospital Ultimovacs Begins Dosing Second Cohort

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science